Other OTC - Delayed Quote USD

ZIVO Bioscience, Inc. (ZIVO)

8.10 +0.10 (+1.25%)
At close: April 26 at 12:20 PM EDT

Key Executives

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. John B. Payne President, CEO & Chairman of the Board 572.75k -- 1948
Mr. Keith R. Marchiando CFO, Treasurer & Secretary 362.5k -- 1962
Dr. Harlan L. Miller III Vice President of Technology & Global Supply -- -- --

ZIVO Bioscience, Inc.

21 East Long Lake Road
Suite 100
Bloomfield Hills, MI 48304
United States
(248) 452 9866 https://www.zivobioscience.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
8

Description

ZIVO Bioscience, Inc., a research and development company, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. Its products indications include poultry gut health, bovine mastitis, canine joint health, human immune modification, algal biomass for human consumption, and biomass for supporting skin health / anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Bloomfield Hills, Michigan.

Corporate Governance

ZIVO Bioscience, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 10, 2024 - May 14, 2024
ZIVO Bioscience, Inc. Earnings Call

Related Tickers

GSTC GlobeStar Therapeutics Corporation
0.0009
0.00%
 
FRES Fresh2 Group Limited
0.5787
+0.02%
 
IPHA Innate Pharma S.A.
2.4600
+2.50%
 
KRBP Kiromic BioPharma, Inc.
3.0800
+13.65%
 
KTTA Pasithea Therapeutics Corp.
7.24
0.00%
 
C4XD.L C4X Discovery Holdings plc
12.00
+27.32%
 
XBIO Xenetic Biosciences, Inc.
4.0899
+8.49%
 
VRPX Virpax Pharmaceuticals, Inc.
3.1000
+8.01%
 
IMRN Immuron Limited
2.6400
+6.02%
 
RLMD Relmada Therapeutics, Inc.
3.8300
+3.51%